| Name | Title | Contact Details |
|---|
Life Science Outsourcing Inc is a Brea, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mountain Health Network is a West Virginia-based not-for-profit health delivery system comprised of Cabell Huntington Hospital, a 303-bed teaching hospital for Marshall University Schools of Medicine, Pharmacy and Nursing; St. Mary`s Medical Center, a 393-bed teaching hospital that operates St. Mary`s Schools of Nursing, Respiratory Care and Medical Imaging; Hoops Family Children`s Hospital, a 72-bed pediatric specialty hospital within Cabell Huntington Hospital; HIMG, a 60-member multi-specialty physician group; and a management agreement with Pleasant Valley Hospital, a 101 acute-bed hospital. Mountain Health is committed to improving the health and well-being of over one million children and adults in 23 counties in West Virginia, southern Ohio, and eastern Kentucky through understanding, respecting, and meeting their needs.
ApprioHealth partners with healthcare organizations to provide Enrollment, Disability, Liability & Insurance Recovery solutions which improve operational and financial performance while positively impacting patient satisfaction. ApprioHealth`s approach combines proven workflows, leading and secure technology, and a certified team of healthcare RCM experts to consistently exceed customers` expectations.
We build applications that use speech and fine motor to detect subtle changes in brain health. We are rooted in neuroscience with an award winning, first to market technology platform that turns the devices we use every day into objective brain health monitors.
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.